• SENSEX 73,246.03
    -352.64 (--0.48%)
  • BANKNIFTY 54,267.40
    292.50 (+0.54%)
  • Jio Platforms
    1,423.80 1,423.80(%)
  • NSE
    1,766.00 1,640.25(%)
  • Reliance Industries
    1,156.60 1,152.30(%)
  • Piramal Pharma
    235.45 235.45(%)
  • United Breweries
    1,316.00 1,845.90(%)
  • Larsen & Toubro
    3,892.00 4,440.00(%)
  • Billionbrains
    190.80 227.00(%)
  • Swiggy
    183.05 174.30(%)
  • Cholaman.Inv.&Fn
    1,557.55 1,952.00(%)
  • Syngene Intl.
    418.75 678.00(%)
  • HDFC Bank
    687.15 1,017.90(%)
  • Lenskart Solut.
    697.50 725.00(%)
  • HDFC AMC
    2,317.50 2,901.00(%)
  • Patanjali Foods
    375.20 613.95(%)
  • Ola Electric
    37.44 51.84(%)
  • One 97
    1,640.50 1,856.50(%)
  • Acutaas Chemical
    3,686.00 1,571.20(%)
  • Sahajanand Medi
    462.10 347.50(%)
  • Jubilant Ingrev.
    581.55 535.30(%)
  • FSN E-Commerce
    345.45 351.00(%)
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison
Overview
  • Overview
  • Key Ratios
  • Financials
  • Shareholding
  • Company Info
  • Peer Comparison

SMS Pharmaceuticals Ltd Pharmaceuticals - Indian - Bulk Drugs

  • Indian Private
  • BSE Code : 25807.0
  • ISIN : INE812G01025
475.45 33 (7.37%)
  • As on 28 Oct 2026 (EOD)

  • Today’s Low

    435.00

  • Today’s High

    478.00

  • Open

    435.00

  • Perv Close

    442.80

  • 52W Low

    270.10

  • 52W High

    494.45

Key Indicators

  • P/E(TTM)

    49.33

  • Mar.Cap (₹Cr.)

    4,452.69

  • Div & Yield %

    0.08

  • Book Value(₹)

    85.93

  • Debt-Equity Ratio

    7.37

  • AGM Date

    28-Oct-2026

  • EPS

    9.67

  • P/E Ratio

    49.33

Financials Ratios

  • Debt-Equity Ratio

    0.54

  • Mar.Cap (₹Cr.)

    4,452.69

  • RONW (%)

    9.87

  • ROCE (%)

    11.69

Score Board

  • Equity (₹ in Cr.)

    9.37

  • BV (₹)

    85.90

  • Sales( ₹ in Cr.)

    886.87

  • NP (in Cr.)

    87.61

  • NP Var(%)

    28.0

  • Div%

    40.0

  • CPS (₹)

    13.60

  • EPS (₹)

    9.40

  • Traded Value (₹ in Lakhs)

    4,467.20

  • 52 Week High

    494.45

  • 52 Week Low

    270.10

  • Price BSE

    477.0

  • Price NSE

    475.00

  • Market Capital( in Cr.)

    4,467.20

  • P/C Ratio

    35.00

  • P/E Ratio

    51.00

  • Price Vs.BV

    9.40

View More
Invest Now!

Navigate The Market With Confidence

Your all-in-one destination for expert investment guidance and streamlined portfolio management solutions

Financials

All Values are in (₹Cr)
Particulars(INCOME) 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar
INCOME :            
Sales Turnover 971.53 835.55 752.35 554.56 555.34 611.60
Excise Duty 84.66 52.80 43.08 32.51 35.47 48.43
Net Sales 886.87 782.75 709.27 522.05 519.87 563.17
Other Income 8.35 6.22 4.46 4.91 5.20 3.45
Stock Adjustments 22.84 64.81 1.00 -36.08 112.50 -26.73
Total Income 918.06 853.78 714.73 490.88 637.57 539.89
EXPENDITURE :            
Raw Materials 516.87 495.54 425.04 299.52 387.80 313.27
Power and Fuel Cost 62.92 56.76 47.12 35.97 32.58 23.31
Employee Cost 75.00 69.72 56.78 50.08 51.02 41.17
Other Manufacturing Expenses 28.06 29.85 26.52 17.86 22.63 16.19
Selling and Administration Expenses 52.96 53.04 35.68 25.28 21.12 19.02
Miscellaneous Expenses 2.72 2.69 2.14 2.51 2.46 2.34
Employee Benefit Expenses 75.00 69.72 56.78 50.08 51.02 41.17
Less: Preoperative Expenditure 0.00 0.00 0.00 0.00 0.00 0.00
Total Expenses 738.53 707.59 593.28 431.23 517.61 415.31
Operating Profit 179.53 146.20 121.45 59.65 119.97 124.59
Interest 23.34 18.54 23.60 21.97 19.16 11.19
Gross Profit 156.19 127.66 97.85 37.68 100.81 113.40
Depreciation 39.92 34.34 31.52 32.13 32.15 22.28
Profit Before Tax 116.27 93.32 66.33 5.55 68.66 91.12
Current Tax 25.93 19.64 15.13 0.00 14.92 16.05
Fringe Benefit tax 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 2.73 5.30 1.78 1.47 -14.30 14.11
Reported Net Profit 87.61 68.38 49.42 4.08 68.04 60.96
Extraordinary Items 0.00 0.03 0.03 -0.04 0.00 -0.01
Adjusted Net Profit 87.61 68.35 49.39 4.12 68.04 60.97
Adjustment below Net Profit 0.03 -0.51 -0.07 -0.21 0.04 -0.16
P & L Balance brought forward 413.52 359.04 322.22 320.88 265.35 214.55
Statutory Appropriations 0.00 0.00 0.00 0.00 0.00 0.00
Appropriations 13.55 13.39 12.54 2.54 12.54 10.00
P & L Balance carried down 487.61 413.52 359.04 322.22 320.88 265.35
Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Preference Dividend 0.00 0.00 0.00 0.00 0.00 0.00
Equity Dividend (%) 40.00 40.00 40.00 30.00 30.00 30.00
Dividend Per Share(Rs) 0.40 0.40 0.40 0.30 0.30 0.30
Earnings Per Share-Unit Curr 9.35 7.71 5.84 0.48 8.04 7.20
Earnings Per Share(Adj)-Unit Curr 9.35 7.71 5.84 0.48 8.04 7.20
Book Value 85.93 74.13 64.02 58.49 58.33 50.59
Book Value(Adj)-Unit Curr 85.93 74.13 64.02 58.49 58.33 50.59

Shareholding Pattern

  • Promoter Group

    68.07%

  • Public Share Holding

    31.93%

Category of Shareholder No of Shares % Holdings Demat Shares Shareholders
A]. Promoter & Group
Foreign (Promoter & Group) - Bodies Corporate 0 0.00 0 0
Foreign (Promoter & Group)-Individuals (Non-Resident / Foreign) 0 0.00 0 0
Foreign Promoter(Institutional) 0 0.00 0 0
Promoter Others 0 0.00 0 0
Sub Total 0 0.00 0 0
[2] INDIAN
Bodies Corporate-Indian (Promoter & Group) 10,066,740 10.75 10,066,740 3
Government(Central / State)-Indian (Promoter & Group) 0 0.00 0 0
Directors & their Relatives-Indian (Promoter & Group) 0 0.00 0 0
Financial Institutions / Banks-Indian (Promoter & Group) 0 0.00 0 0
Individuals / Hindu Undivided Family-Indian (Promoter & Group) 53,678,270 57.32 53,678,270 4
Partnership Firms-Indian (Promoter & Group) 0 0.00 0 0
Persons Acting in Concert 0 0.00 0 0
Trusts 0 0.00 0 0
Others 0 0.00 0 0
Sub Total 63,745,010 68.07 63,745,010 7
Total ShareHolding for Promoter & Group
B]. Publice Share Holding
1] Institution
Government(Central / State) 0 0.00 0 0
Clearing Members 0 0.00 0 0
Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
Financial Institutions / Banks 0 0.00 0 0
Foreign Bank 0 0.00 0 0
Foreign Bodies Corporate/OCBs/FBC 0 0.00 0 0
Foreign Collaborators 0 0.00 0 0
Foreign Institutional Investors 1,101,513 1.18 1,101,513 23
Foreign Venture Capital Investors 0 0.00 0 0
Foreign Institution Other 0 0.00 0 0
Insurance Companies 0 0.00 0 0
Mutual Funds / UTI 1,190 0.00 1,190 2
Individuals (Non-Resident / Foreign) 0 0.00 0 0
NSDL Intransit 0 0.00 0 0
Others 181,827 0.19 181,827 5
Trusts 0 0.00 0 0
Venture Capital Funds 0 0.00 0 0
Sub total 1,284,530 1.37 1,284,530 30
2] Non Institution
Bodies Corporate 1,735,850 1.85 1,735,750 168
Clearing Members 226 0.00 226 2
Directors of their Relatives 0 0.00 0 0
Employees 0 0.00 0 0
Escrow Account 0 0.00 0 0
Foreign Corporate Bodies 0 0.00 0 0
Foreign Direct Investments 0 0.00 0 0
NRIs/Foreign Individuals/Foreign Nationals 2,022,403 2.16 2,021,503 490
Foreign Non Institution Other 0 0.00 0 0
Hindu Undivided Families 0 0.00 0 0
Indian Public 0 0.00 0 0
Individuals holding nominal share capital in excess of Rs. 1 lakh 7,025,925 7.50 7,025,925 9
Individuals holding nominal share capital up to Rs. 1 lakh 17,188,096 18.35 16,969,255 34,191
Market Maker 0 0.00 0 0
NSDL Transit 0 0.00 0 0
Shares in transit 0 0.00 0 0
Societies 0 0.00 0 0
Trust & Foundation 967 0.00 967 2
Others 648,523 0.69 648,523 4
Sub Total 28,622,490 30.56 28,402,649 34,867
Total Public Shareholding
C]. Shares held by Custodians and against which Depository Receipts have been issued
ADR 0 0.00 0 0
GDR 0 0.00 0 0
Other Custodians 0 0.00 0 0
Total Shares held by Custodians and against which Depository Receipts have been issued 0 0.00 0 0
Grand Total ( A + B + C ) 93,652,030 100.00 93,432,189 34,904

Company Background

SMS Pharmaceuticals LtdPharmaceuticals - Indian - Bulk Drugs

  • SMS Pharmaceuticals Ltd
  • BSE Code : 25807.0
  • ISIN : INE812G01025

  • Incorporation Year

    1987

  • Registered Office

    8th Floor Trendset Jayabheri
    Connect Kondapur Serilingampal, Hyderabad,
    Telangana-500084

  • Telephone

  • FAX

  • Chairman

    P Ramesh Babu

  • Managing Director

    P Ramesh Babu

  • Company Secretary

    Thirumalesh Tumma

  • Auditor

    Suryanarayana & Suresh

  • Face Value

    1

  • Listing

    NSE

  • Registrar

    Aarthi Consultants Pvt Ltd
    1-2-285 Domalguda,
    ,
    Mumbai - Hyderabad - 500 029

SMS Pharmaceuticals Ltd Peer Comparison

Profit & Loss
Financial Ratios
Balance Sheet
Select Company Name LTP (₹) Revenue Sales P/E Ratio ROCE %
SMS Pharma. 477.00 895.22 971.53 49.33 12.95
Abbott India 26,278.90 7,217.19 6,929.05 34.58 43.78
Astrazeneca Phar 6,234.70 2,304.07 2,275.58 91.89 27.86
Glaxosmi. Pharma 2,496.65 3,932.76 3,790.20 39.88 58.17
Novartis India 1,805.95 393.10 354.33 45.60 15.94
Cipla 1,360.00 20,102.60 18,979.95 41.45 13.88
Bliss GVS Pharma 650.05 773.53 729.81 60.41 12.51
Amrutanjan Healt 491.10 520.13 502.55 26.30 24.16
Fermenta Biotec. 443.85 474.15 450.25 20.72 18.77
Guj. Themis Bio. 355.25 168.25 165.82 94.99 18.05
Ambalal Sarabhai 35.73 19.52 3.94 66.17 6.77